|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.80 EUR | +0.58% |
|
-2.87% | +1.26% |
| 12-04 | BioMérieux Launches Two Dedicated Equine Tests |  |
| 11-10 | UBS Maintains Buy Rating on BioMérieux, Confirms Price Target | |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €123.46 | +17.81% | 14 | ||||||
| US$100.82 | -1.18% | 22 | ||||||
| US$38.33 | +32.83% | 9 | ||||||
| CN¥69.64 | +16.32% | 11 | ||||||
| US$80.93 | +27.85% | 14 | ||||||
| €92.5 | +48.62% | 12 | ||||||
| CN¥44.48 | +23.05% | 4 | ||||||
| US$16.57 | -6.74% | 14 | ||||||
| SEK 193.5 | +36.94% | 4 | ||||||
| CN¥25.95 | +29.56% | 2 | ||||||
| CN¥26.09 | +25.43% | 3 | ||||||
| - | - | CN¥20 | +32.98% | 1 | ||||
| CN¥28.33 | +27.02% | 4 | ||||||
| US$37.25 | -3.6% | 8 | ||||||
| - | - | - | - | - | ||||
| - | CN¥14.9 | +29.79% | 1 | |||||
| Average | 60.85 | +22.44% | 8 | ||||||
| Weighted average by Cap. | 81.75 | +18.91% | 13 |
- Stock Market
- Equities
- BIM Stock
- Sector bioMérieux
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition